2m 2m 2m 2m 2m 2m 2m
Talphera (TLPH)
NASDAQ
$1.31+$0.03 (+2.34%)
Price as of Aug 03, 2026 12:43 PM EDT- $66.4MMarket Cap
- 218.09%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Talphera (TLPH)
$1.31+$0.03 (+2.34%)
TLPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.28 | ||
Change | -$0.07 (-5.54%) | ||
Open | $1.35 | ||
High | $1.41 | ||
Low | $1.28 | ||
Previous Close | $1.35 | ||
Volume | 197,348 | ||
30-Day Average Volume | 417,373 | ||
1-Week Change | -5.19% | ||
1-Month Change | 24.27% | ||
1-Year Change | 218.09% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 51.9M | ||
Total Assets | $30.2M | ||
Market Cap | $66.4M | ||
Enterprise Value | $62.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$2.6M | ||
Free Cash Flow | -$3.4M | ||
EBIT | -$2.6M | ||
EBITDA | -$2.6M | ||
Net Working Capital | $17.3M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -32 | ||
PEG | -1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue